Pataday® (olopatadine) – First-time Generic
June 9, 2017 – Teva launched its AT-rated generic version of Alcon Laboratories’ Pataday (olopatadine) 0.2% ophthalmic solution, for the treatment of ocular itching associated with allergic conjunctivitis.
Download PDF
